Medical Facilities Corporation

TSX:DR.TO

Medical - Care Facilities

Healthcare
$17.43 +1.01%

+$0.18 today

Market cap
$282.59M
Beta
0.34
P/E (TTM)
8.7
EPS (TTM)
$1.47
Dividend yield
2.00%
52W Low $13.59High $18.79

Volume 0.04M

Average 0.02M

DR.TO Net Income

Bottom-line profit, the starting point for calculating cash from operations.

Medical Facilities CorporationTSX: DR.TO

Net Income · Q1 FY2026 · quarter ended Mar 2026

Net income declines year over year

Q1 FY2026 net income of $7.79M fell 13.3% year over year, ahead of the -68.8% change in trailing-twelve-month net income. Sequentially, it rose 180.0% from the prior quarter. Over 3 fiscal years it compounded at +19.7% a year.

Context

  • Net income amounted to 8.2% of revenue in FY2025, down 23.7 pp from a year earlier.
  • Net income increased in 2 of the last 3 fiscal years.

What to watch

Whether net income reaches the consensus estimate from 1 analysts of $41.16M (+95.2%) for the fiscal year ending Dec 2026, a step up from the -80.0% reported in FY2025.

Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
$7.79M+180.0% QoQ
Last fiscal yearDec 2025
$21.08M-80.0% YoY
LTMMar 2026
$33.14M-68.8% YoY
Net Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-13.3%-64.7%-51.4 pp
1 year-80.0%+95.2%+175.2 pp
3-year CAGR+19.7%+19.0%-0.7 pp
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Income history

USD · from the cash flow

Latest · FY2025
21.08M USD
Year-over-year change
-80.0%
4-year CAGR
-17.9%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Income vs competitors

How DR.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so net income is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -68.8% is the 7th highest of 9, against a peer median of -9.3%.
  • Net income amounts to 10.9% of revenue for DR.TO, versus a peer median of 17.2%.
DR.TO Competitors
Net Income for DR.TO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
WEED.TOCanopy Growth CorporationLTM Mar 2026CA$263.55M CAD-56.4%-28.6%84.8%
EPRX.TOEupraxia Pharmaceuticals Inc.LTM Mar 2026$42.94M USD+85.5%+18.4%—
PRN.TOProfound Medical Corp.LTM Mar 2026$38.94M USD+20.4%+14.1%207.6%
XLY.TOAuxly Cannabis Group Inc.LTM Mar 2026CA$33.21M CAD+52.5%—20.9%
DR.TOMedical Facilities CorporationLTM Mar 2026$33.14M USD-68.8%+19.7%10.9%
CRRX.TOCareRx CorporationLTM Mar 2026CA$27.07M CAD+820.5%—7.2%
OGI.TOOrganiGram Holdings Inc.LTM Mar 2026CA$25.21M CAD-249.3%—9.2%
TSND.TOTerrAscend Corp.LTM Mar 2026$20.19M USD-71.2%—7.7%
FRX.TOFennec Pharmaceuticals Inc.LTM Mar 2026$8.81M USD-39.0%-25.7%17.2%
Peer median (excluding DR.TO) —-9.3%-5.8%17.2%

Competitors are the stored peer set for DR.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income46.49M12.3M44M105.56M21.08M
Depreciation & Amortization26.77M20.76M21.54M19.37M15.66M
Deferred Income Tax4.4M5.21M8.33M(3.67M)6.01M
Stock-Based Compensation292K(667K)(397K)(246K)0
Change in Working Capital(10.45M)(6.21M)(488K)(1.64M)(3.96M)
Accounts Receivables(1.23M)(2.6M)1.03M5.23M(4.02M)
Inventory659K1.42M(205K)(476K)(659.34K)
Accounts Payables(525K)2.46M(2.48M)(495K)1.86M
Other Working Capital(9.35M)(7.5M)1.17M(5.9M)(1.14M)
Other Non-Cash Items8.14M25.63M(183K)(36.09M)7.16M
Operating Cash Flow75.64M57.01M72.71M83.28M45.95M
Capital Expenditures(8.42M)(6.72M)(16.05M)(7.07M)(4.96M)
Acquisitions (Net)(267K)943K2.39M92.49M826.21K
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities(267K)943K2.39M00
Investing Cash Flow(8.69M)(5.78M)(13.67M)85.42M(4.14M)
Debt Repayment(30.05M)(6.47M)(28.84M)(32.82M)(2.62M)
Common Stock Issued00000
Common Stock Repurchased(2.07M)(38.38M)(7.42M)(16.61M)(64.78M)
Dividends Paid(6.92M)(7.5M)(6.07M)(6.1M)(5.18M)
Other Financing Activities(33.02M)(25M)(27.49M)(28.73M)(34.72M)
Financing Cash Flow(72.06M)(77.35M)(69.83M)(84.26M)(107.3M)
Effect of Forex Changes(34K)(3K)(34K)(59K)(4.77M)
Net Change in Cash(5.14M)(26.12M)(10.81M)84.38M(70.26M)
Free Cash Flow67.22M50.3M56.66M76.22M40.99M

Medical Facilities Corporation

TSX:DR.TO

Intrinsic Alpha fair value

Locked

Current Price

$17.43

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.